Sanjay Shukla - Net Worth and Insider Trading
Sanjay Shukla Net Worth
The estimated net worth of Sanjay Shukla is at least $471,773 dollars as of 2024-12-26. Sanjay Shukla is the President and CEO of aTyr Pharma Inc and owns about 136,548 shares of aTyr Pharma Inc (ATYR) stock worth over $471,773. Details can be seen in Sanjay Shukla's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Sanjay Shukla has not made any transactions after 2024-05-31 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Sanjay Shukla
Sanjay Shukla Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Sanjay Shukla owns 1 companies in total, including aTyr Pharma Inc (ATYR) .
Click here to see the complete history of Sanjay Shukla’s form 4 insider trades.
Insider Ownership Summary of Sanjay Shukla
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ATYR | aTyr Pharma Inc | 2024-05-31 | Chief Medical Officer |
Sanjay Shukla Latest Holdings Summary
Sanjay Shukla currently owns a total of 1 stock. Sanjay Shukla owns 136,548 shares of aTyr Pharma Inc (ATYR) as of May 31, 2024, with a value of $471,773.
Latest Holdings of Sanjay Shukla
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ATYR | aTyr Pharma Inc | 2024-05-31 | 136,548 | 3.46 | 471,773 |
Holding Weightings of Sanjay Shukla
Sanjay Shukla Form 4 Trading Tracker
According to the SEC Form 4 filings, Sanjay Shukla has made a total of 12 transactions in aTyr Pharma Inc (ATYR) over the past 5 years, including 10 buys and 2 sells. The most-recent trade in aTyr Pharma Inc is the acquisition of 20,000 shares on May 31, 2024, which cost Sanjay Shukla around $36,200.
Insider Trading History of Sanjay Shukla
- 1
Sanjay Shukla Trading Performance
GuruFocus tracks the stock performance after each of Sanjay Shukla's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Sanjay Shukla is 4.08%. GuruFocus also compares Sanjay Shukla's trading performance to market benchmark return within the same time period. The performance of stocks bought by Sanjay Shukla within 3 months outperforms 6 times out of 10 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Sanjay Shukla's insider trading performs compared to the benchmark.
Performance of Sanjay Shukla
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 4.98 | | | | | |
| Relative Return to S&P 500(%) | 3.22 | | | | | |
Sanjay Shukla Ownership Network
Sanjay Shukla Owned Company Details
What does aTyr Pharma Inc do?
Who are the key executives at aTyr Pharma Inc?
Sanjay Shukla is the Chief Medical Officer of aTyr Pharma Inc. Other key executives at aTyr Pharma Inc include Chief Financial Officer Jill Marie Broadfoot , See Remarks Nancy Krueger , and director & CEO and Executive Chairman John Mendlein .
aTyr Pharma Inc (ATYR) Insider Trades Summary
Over the past 18 months, Sanjay Shukla made 4 insider transaction in aTyr Pharma Inc (ATYR) with a net purchase of 65,000. Other recent insider transactions involving aTyr Pharma Inc (ATYR) include a net purchase of 3,410 shares made by Jill Marie Broadfoot , a net purchase of 100,000 shares made by Paul Schimmel , and a net purchase of 50,000 shares made by Timothy P Coughlin .
In summary, during the past 3 months, insiders sold 0 shares of aTyr Pharma Inc (ATYR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,590 shares of aTyr Pharma Inc (ATYR) were sold and 225,000 shares were bought by its insiders, resulting in a net purchase of 223,410 shares.
aTyr Pharma Inc (ATYR)'s detailed insider trading history can be found in Insider Trading Tracker table.
aTyr Pharma Inc Insider Transactions
Sanjay Shukla Mailing Address
Above is the net worth, insider trading, and ownership report for Sanjay Shukla. You might contact Sanjay Shukla via mailing address: C/o Atyr Pharma, Inc., 10240 Sorrento Valley Road, Suite 300, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
